Robert Cochrane
Dentist, Periodontics Fort Dodge, IA Doctor of Dentistry
NPI 1144309725 CMS profile 233344
1611 First Ave North, Fort Dodge, IA 50501
General payments
$304
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Robert Cochrane of Fort Dodge, IA is reported in the CMS Open Payments database as having received $304 across 12 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 38th percentile of Dentist, Periodontics profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $78 | 2 | |
| 2022 | General | $83 | 2 | |
| 2021 | General | $15 | 1 | |
| 2020 | General | $34 | 2 | |
| 2019 | General | $94 | 5 |
Beside peers
- Robert Cochrane
- Dentist, Periodontics median
- Middle half of Dentist, Periodontics
- National median
In program year 2025, general payments to Robert Cochrane were reported at $0. Among 2,732 Dentist, Periodontics profiles paid that year, the median was $112 and the middle half received between $42 and $307.
Show as a table
| Year | Robert Cochrane | Dentist, Periodontics median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $94 | $129 | $42–$367 | $163 |
| 2020 | $34 | $90 | $35–$265 | $114 |
| 2021 | $15 | $125 | $42–$411 | $132 |
| 2022 | $83 | $123 | $43–$364 | $149 |
| 2023 | $78 | $125 | $45–$358 | $160 |
| 2024 | $0 | $119 | $42–$350 | $164 |
| 2025 | $0 | $112 | $42–$307 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 12 drugsPart D claims
722
Drug cost
$5,209
Branded share of claims
28.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 160 | $1,367 | |
| Dexamethasone | Generic | 55 | $1,315 | |
| Clobetasol Propionate | Generic | 24 | $573 | |
| Amoxicillin | Generic | 250 | $565 | |
| Doxycycline Hyclate | Generic | 12 | $382 | |
| Cephalexin | Generic | 60 | $295 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 27 | $193 | |
| Chlorhexidine Gluconate | Generic | 39 | $168 | |
| Sodium Fluoride Fluoride (Sodium) | Brand | 17 | $142 | |
| Clindamycin Hcl | Generic | 31 | $95 |
The 10 drugs with the highest cost, of 12 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.
Records
12 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Periodontics in Iowa
Sarah Rinehart
Dentist, Periodontics · Iowa City, IA
Derek Borgwardt
Dentist, Periodontics · Iowa City, IA
Vrushali Pavan Abhyankar
Dentist, Periodontics · Iowa City, IA
John Tingey
Dentist, Periodontics · Iowa City, IA
Carlos-Andres Garaicoa-Pazmino
Dentist, Periodontics · Iowa City, IA
Michael Franzman
Dentist, Periodontics · Davenport, IA
Related records
Dentist, Periodontics in Iowa
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Periodontics
Everyone recorded under this specialty, nationwide.
Doctors in Iowa
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.